臨床・分子診断向けAI市場

世界の臨床・分子診断向けAIの市場規模は、2024年の26億米ドルから、予測期間中はCAGR 27.6%で推移し、2029年末には89億米ドルの規模に成長すると予測されています。

当レポートでは、世界の臨床・分子診断向けAIの市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、新興技術および技術開発の動向、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

• 市場見通し
• 調査範囲
• 市場概要

第2章 市場概要

• 概要
• AIの歴史
• 機械学習の台頭
• 機械学習 vs ディープラーニング vs ニューラルネットワーク
• 機械学習のタイプ
• MLアルゴリズムの利点と欠点
• ヘルスケアにおけるAI
• 臨床診断におけるAI
• 分子診断におけるAI

第3章 市場力学

• 概要
• 市場促進要因
• AIヘルス分野への投資
• 慢性疾患および感染症の増加
• 技術の進歩
• 個別化医療の需要
• 市場抑制要因
• AIベースの技術の導入への消極性
• データセキュリティ
• 規制上の課題
• 市場機会
• AI搭載ソフトウェア
• 新興市場における未開拓の機会

第4章 規制構造

第5章 新興技術と開発

• 最新技術・開発
• 機械学習アルゴリズム
• ディープラーニング
• 生成AI
• 自然言語処理 (NLP)
• ゲノムAI
• クラウドベースのソリューション

第6章 市場セグメンテーション分析

• 市場動向
• セグメンテーションの内訳
• 臨床・分子診断向けAI：世界市場
• 分子診断
• 臨床診断
• 市場分析：コンポーネント別
• ソフトウェア
• サービス
• ハードウェア
• 地理的内訳
• 市場分析：地域別
• 北米
• 欧州
• アジア太平洋
• その他の地域

第7章 競合情報

第8章 臨床・分子診断向けAIの持続可能性：ESGの観点

• 環境の持続可能性
• 環境へのプラスの影響
• 環境への悪影響
• 社会：AIが社会全体に利益をもたらすことを保証
• ガバナンスの影響

第9章 付録

• 調査手法
• 出典
• 略語
• 企業プロファイル
• ATOMWISE INC.
• F. HOFFMANN-LA ROCHE LTD.
• FUJIFILM HOLDINGS CORP.
• GE HEALTHCARE
• ILLUMINA INC.
• KONINKLIJKE PHILIPS N.V.
• MEDTRONIC
• MICROSOFT CORP.
• SIEMENS HEALTHINEERS AG
• THERMO FISHER SCIENTIFIC INC.
• Vendors
• BUTTERFLY NETWORK INC.
• ENLITIC
• INTEL CORP.
• MERATIVE
• NVIDIA CORP.
• QURE.AI
• SYNAPSICA HEALTHCARE PVT LTD.

List of Tables

• Summary Table A : Global Market for AI in Clinical and Molecular Diagnostics, by Type, Through 2029
• Summary Table B : Global Market for AI in Clinical and Molecular Diagnostics, by Region, Through 2029
• Table 1 : Regulations Pertaining to AI Medical Diagnostics
• Table 2 : Global Market for AI in Clinical and Molecular Diagnostics, Through 2029
• Table 3 : Global Market for AI in Clinical and Molecular Diagnostics, by Type, Through 2029
• Table 4 : Global Market for AI in Molecular Diagnostics, by Application, Through 2029
• Table 5 : Incidence of Cancer, by Region, 2022
• Table 6 : Number of DALYs for Neurological Disorders and Share of Global DALYs Projected for 2005 and 2030
• Table 7 : Global Market for AI in Molecular Diagnostics, by Product Type, Through 2029
• Table 8 : Global Market for AI in Clinical Diagnostics, by Test, Through 2029
• Table 9 : Global Market for AI in Clinical Diagnostics, by Product, Through 2029
• Table 10 : Global Market for AI in Clinical and Molecular Diagnostics, by Component, Through 2029
• Table 11 : Global Market for AI in Clinical and Molecular Diagnostics, by Region, Through 2029
• Table 12 : North American Market for AI in Clinical and Molecular Diagnostics, by Country, Through 2029
• Table 13 : European Market for AI in Clinical and Molecular Diagnostics, by Country, Through 2029
• Table 14 : Asia-Pacific Market for AI in Clinical and Molecular Diagnostics, by Country, Through 2029
• Table 15 : RoW Market for AI in Clinical and Molecular Diagnostics, by Sub-Region, Through 2029
• Table 16 : Recent Initiatives in the Market for AI in Clinical and Molecular Diagnostics, 2024
• Table 17 : Report Sources
• Table 18 : Abbreviations Used in this Report
• Table 19 : Atomwise Inc.: Company Snapshot
• Table 20 : Atomwise Inc.: Product Portfolio
• Table 21 : Atomwise Inc: News/Key Developments, 2022
• Table 22 : F. Hoffmann-La Roche Ltd.: Company Snapshot
• Table 23 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
• Table 24 : F. Hoffmann-La Roche Ltd.: Product Portfolio
• Table 25 : Fujifilm Holdings Corp.: Company Snapshot
• Table 26 : Fujifilm Holdings Corp.: Financial Performance, FY 2022 and 2023
• Table 27 : Fujifilm Holdings Corp.: Product Portfolio
• Table 28 : GE HealthCare: Company Snapshot
• Table 29 : GE HealthCare: Financial Performance, FY 2022 and 2023
• Table 30 : GE HealthCare: Product Portfolio
• Table 31 : Illumina: Company Snapshot
• Table 32 : Illumina: Financial Performance, FY 2022 and 2023
• Table 33 : Illumina: Product Portfolio
• Table 34 : Koninklijke Philips N.V.: Company Snapshot
• Table 35 : Koninklijke Philips N.V.: Financial Performance, FY 2022 and 2023
• Table 36 : Koninklijke Philips N.V.: Product Portfolio
• Table 37 : Medtronic: Company Snapshot
• Table 38 : Medtronic: Financial Performance, FY 2022 and 2023
• Table 39 : Medtronic: Product Portfolio
• Table 40 : Microsoft Corp.: Company Snapshot
• Table 41 : Microsoft Corp.: Financial Performance, FY 2022 and 2023
• Table 42 : Microsoft Corp.: Product Portfolio
• Table 43 : Microsoft Corp.: News/Key Developments, 2024
• Table 44 : Siemens Healthineers AG: Company Snapshot
• Table 45 : Siemens Healthineers AG: Financial Performance, FY 2022 and 2023
• Table 46 : Siemens Healthineers AG: Product Portfolio
• Table 47 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 48 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
• Table 49 : Thermo Fisher Scientific Inc.: Product Portfolio
• Table 50 : Butterfly Network Inc.: Company Snapshot
• Table 51 : Butterfly Network Inc.: Financial Performance, FY 2022 and 2023
• Table 52 : Butterfly Network Inc.: Product Portfolio
• Table 53 : Enlitic: Company Snapshot
• Table 54 : Enlitic: Product Portfolio
• Table 55 : Intel Corp.: Company Snapshot
• Table 56 : Intel Corp.: Financial Performance, FY 2022 and 2023
• Table 57 : Intel Corp.: Product Portfolio
• Table 58 : Merative: Company Snapshot
• Table 59 : Merative: Product Portfolio
• Table 60 : NVIDIA Corp.: Company Snapshot
• Table 61 : NVIDIA Corp.: Financial Performance, FY 2022 and 2023
• Table 62 : NVIDIA Corp.: Product Portfolio
• Table 63 : Qure.ai: Company Snapshot
• Table 64 : Qure.ai: Product Portfolio
• Table 65 : Synapsica Healthcare Pvt Ltd.: Company Snapshot
• Table 66 : Synapsica Healthcare Pvt Ltd.: Product Portfolio

List of Figures

• Summary Figure A : Global Market for AI in Clinical and Molecular Diagnostics, by Type, 2021-2029
• Summary Figure B : Global Market for AI in Clinical and Molecular Diagnostics, by Region, 2021-2029
• Figure 1 : Market Dynamics of AI in Clinical and Molecular Diagnostics
• Figure 2 : Global Market Shares of AI in Clinical and Molecular Diagnostics, by Type, 2023
• Figure 3 : Global Market Shares of AI in Molecular Diagnostics, by Application, 2023
• Figure 4 : Global Deaths from Cancer, 2015 and 2030
• Figure 5 : Global Market Shares of AI in Molecular Diagnostics, by Product Type, 2023
• Figure 6 : Global Market Shares of AI in Clinical Diagnostics, by Test, 2023
• Figure 7 : Global Market Shares of AI in Clinical Diagnostics, by Product, 2023
• Figure 8 : Global Market Shares of AI in Clinical and Molecular Diagnostics, by Component, 2023
• Figure 9 : Global Market Shares of AI in Clinical and Molecular Diagnostics, by Region, 2023
• Figure 10 : North American Market Shares of AI in Clinical and Molecular Diagnostics, by Country, 2023
• Figure 11 : European Market Shares of AI in Clinical and Molecular Diagnostics, by Country, 2023
• Figure 12 : Asia-Pacific Market Shares of AI in Clinical and Molecular Diagnostics, by Country, 2023
• Figure 13 : RoW Market Shares of AI in Clinical and Molecular Diagnostics, by Sub-Region, 2023
• Figure 14 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
• Figure 15 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
• Figure 16 : Fujifilm Holdings Corp.: Revenue Share, by Business Unit, FY 2023
• Figure 17 : Fujifilm Holdings Corp.: Revenue Share, by Country/Region, FY 2023
• Figure 18 : GE HealthCare: Revenue Share, by Business Unit, FY 2023
• Figure 19 : GE HealthCare: Revenue Share, by Country/Region, FY 2023
• Figure 20 : Illumina: Revenue Share, by Business Unit, FY 2023
• Figure 21 : Illumina: Revenue Share, by Country/Region, FY 2023
• Figure 22 : Koninklijke Philips N.V.: Revenue Share, by Business Unit, FY 2023
• Figure 23 : Koninklijke Philips N.V.: Revenue Share, by Country/Region, FY 2023
• Figure 24 : Medtronic: Revenue Share, by Business Unit, FY 2023
• Figure 25 : Medtronic: Revenue Share, by Country/Region, FY 2023
• Figure 26 : Microsoft Corp.: Revenue Share, by Business Unit, FY 2023
• Figure 27 : Microsoft Corp.: Revenue Share, by Country/Region, FY 2023
• Figure 28 : Siemens Healthineers AG: Revenue Share, by Business Unit, FY 2023
• Figure 29 : Siemens Healthineers AG: Revenue Share, by Country/Region, FY 2023
• Figure 30 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 31 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 32 : Butterfly Network Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 33 : Butterfly Network Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 34 : Intel Corp.: Revenue Share, by Business Unit, FY 2023
• Figure 35 : Intel Corp.: Revenue Share, by Country/Region, FY 2023
• Figure 36 : NVIDIA Corp.: Revenue Share, by Business Unit, FY 2023
• Figure 37 : NVIDIA Corp.: Revenue Share, by Country/Region, FY 2023

The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.

Report Scope

This report on the global market for AI in clinical and molecular diagnostics entails a comprehensive analysis of the market size, growth trends and segmentation by technology and application. It examines drivers, challenges and opportunities influencing the adoption of AI technologies in clinical and molecular diagnostics, focusing on specific applications in imaging, genomics and laboratory diagnostics. The report provides perspectives on the competitive environment, featuring profiles of leading companies and their strategic initiatives, as well as regional analyses that address the specific market dynamics in North America, Europe, Asia-Pacific, and the Rest of the World (RoW), which in this report includes Latin America and the Middle East and Africa. It also identifies emerging trends, such as the integration of AI in personalized medicine and telehealth. This report is an essential reference for stakeholders, including healthcare providers, technology developers and policymakers, seeking to navigate and capitalize on the evolving AI landscape in diagnostics.

Report Includes

• 27 data tables and 41 additional tables
• An analysis of the current and future global markets for AI in clinical and molecular diagnostics
• Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
• Estimates of the market size and revenue forecasts for the global market for AI in clinical and molecular diagnostics, with market share analysis by type of services, devices, and region
• Discussion of the rising prevalence of chronic diseases, and technological advances in biomarker discovery, disease progression prediction, and personalized treatment strategies
• Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
• Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG scores, and consumer attitudes
• Competitive intelligence, including companies' market shares, recent M&A activity and venture funding
• Profiles of the leading companies, including Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., Koninklijke Philips N.V., Fujifilm Holdings Corp., and Merative

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• History of AI
• Rise of Machine Learning
• Machine Learning vs. Deep Learning vs. Neural Networks
• Types of Machine Learning
• Advantages and Disadvantages of ML Algorithms
• AI in Healthcare
• AI in Clinical Diagnostics
• AI in Molecular Diagnostics

Chapter 3 Market Dynamics

• Overview
• Market Drivers
• Investment in the AI Health Sector
• Increasing Prevalence of Chronic and Infectious Diseases
• Technological Advances
• Demand for Personalized Medicine
• Market Restraints
• Practitioners Reluctant to Adopt AI-based Technologies
• Data Security
• Regulatory Challenges
• Market Opportunities
• Software with AI
• Untapped Opportunities in Developing Markets

Chapter 4 Regulatory Structure

Chapter 5 Emerging Technologies and Developments

• Latest Technologies/Developments
• Machine Learning Algorithms
• Deep Learning
• Generative AI
• Natural Language Processing (NLP)
• Genomic AI
• Cloud-Based Solutions

Chapter 6 Market Segmentation Analysis

• Market Trends
• Segmentation Breakdown
• AI in Clinical and Molecular Diagnostics: Global Markets
• Molecular Diagnostics
• Clinical Diagnostics
• Market Analysis by Component
• Software
• Services
• Hardware
• Geographic Breakdown
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 Competitive Intelligence

Chapter 8 Sustainability in AI in Clinical and Molecular Diagnostics: An ESG Perspective

• Environmental Sustainability
• Positive Environmental Impacts
• Negative Environmental Impacts
• Social: Ensuring that AI Benefits All Society
• Governance Impacts

Chapter 9 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• ATOMWISE INC.
• F. HOFFMANN-LA ROCHE LTD.
• FUJIFILM HOLDINGS CORP.
• GE HEALTHCARE
• ILLUMINA INC.
• KONINKLIJKE PHILIPS N.V.
• MEDTRONIC
• MICROSOFT CORP.
• SIEMENS HEALTHINEERS AG
• THERMO FISHER SCIENTIFIC INC.
• Vendors
• BUTTERFLY NETWORK INC.
• ENLITIC
• INTEL CORP.
• MERATIVE
• NVIDIA CORP.
• QURE.AI
• SYNAPSICA HEALTHCARE PVT LTD.